False-positive results for immunoglobulin M serologic results: Explanations and examples

Journal of the Pediatric Infectious Diseases Society

Volumn 2, Issue 1, 2013, Pages 87-90

  Woods, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

COCCIDIOIDES; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; MEASLES; NOTE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; WEST NILE FLAVIVIRUS;

EID: 84939631770     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pis133     Document Type: Note

References (28)

1. Seriburi V, Ndukwe N, Change Z, et al. High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect 2011; 18:1236-40.
2. State of Alaska Epidemiology. False positive laboratory test results for measles-some disease actually parvovirus B19. State of Alaska Epidemiol Bull 1994; No. 26. Available at: http://www.epi.hss.state.ak.us/bulletins/docs/b1994_26.htm. Accessed September 20, 2012.
3. Farmer A, Rea V, Sears SD, Bernier B. Notes from the field: false-positive measles test - Maine, February 2012. MMWR Morb Mortal Wkly Rep 2012; 61:396.
4. Ciccone FH, Carvalhanas TR, Afonso AM, et al. Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, State of Sao Paulo, Brazil, 2000-2004. Rev Soc Bras Med Trop 2010; 43:234-9.
5. Dietz V, Rota J, Izurieta H, et al. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas. Bull World Health Org 2004; 82:852-7.
6. Navalpotro D, Gimeno C, Navarro D. Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection. J Med Virol 2006; 78:1449-51.
7. Jenkerson SA, Beller M, Middaugh JP, Erdman DD. False positive rubeola IgM tests. N Engl J Med 1995; 332:1103-4.
8. Berth M, Bosmans E. Acute parvovirus B19 infection frequently causes false-positive results in Epstein-Barr virus- and herpes simplex virus-specific immunoglobulin M determinations done on the Liaison platform. Clin Vaccine Immunol 2009; 16:372-5.
9. Post JJ, Chan MK, Whybin LR, et al. Positive Epstein-Barr virus and cytomegalovirus IgM assays in primary HIV infection. J Med Virol 2011; 83:1406-9.
10. Wong SJ, Boyle RH, Demarest VL, et al. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol 2003; 41:4217-23.
11. Kaplan JE, Schonberger LB. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg 1986; 35:840-4.
12. Amano K, Mizushiri S, Fujii S, et al. Immunological characterization of lipopolysaccharides from Proteus strains used in Weil-Felix test and reactivity with patient sera of tsutsugamushi diseases. Microbiol Immunol 1990; 34:135-45.
13. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997; 3:213-21.
14. Centers for Disease Control and Prevention. Public health consequences of a false-positive laboratory test result for Brucella-Florida, Georgia, and Michigan, 2005. MMWR Morb Mortal Wkly Rep 2008; 57:603-5.
15. Guttormsen HK, Baker CJ, Nahm MH, et al. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun 2002; 70:1724-38.
16. Yu X, Gray B, Chang S, et al. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis 1999; 180:1569-76.
17. Robbins JB, Schneerson R, Xie G, et al. Capsular polysaccharide vaccine for group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2. Proc Natl Acad Sci 2011; 108:17871-5.
18. Bjerner J. Human anti-immunoglobulin antibodies interfering in immunometric assays. Scand J Clin Lab Invest 2005; 65:349-64.
19. Marks V. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin Chem 2002; 48:2008-16.
20. Williams RC. Rheumatoid factors in subacute bacterial endocarditis and other infectious diseases. Scand J Rheumatol Suppl 1988; 75:300-8.
21. Meurman OH, Ziola BR. IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies. J Clin Pathol 1978; 31:483-7.
22. Ismail AA, Ismail AA, Ismail Y. Probabilistic Bayesian reasoning can help identifying potentially wrong immunoassays results in clinical practice: even when they appear 'not-unreasonable'. Ann Clin Biochem 2011; 48:65-71.
23. Barcelo Martin B, Marquet P, Ferrer JM, et al. Rheumatoid factor interference in a tacrolimus immunoassay. Ther Drug Monit 2009; 31:743-5.
24. Tipples GA, Hamkar R, Mohktari-Azad T, et al. Assessment of immunoglobulin M enzyme immunoassays for diagnosis of measles. J Clin Microbiol 2003; 41:4790-2.
25. Centers for Disease Control and Prevention. False-positive results with a commercially available West Nile virus immunoglobulin M assay - United States, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:458-60.
26. Welch RJ, Anderson BL, Litwin CM. Evaluation of a new commercial enzyme immunoassay for the detection of IgM antibodies to West Nile virus using a ratio method to eliminate nonspecific reactivity. J Clin Lab Anal 2008; 22:362-6.
27. Centers for Disease Control and Prevention. West Nile virus diagnostic testing. Available at: http://www.cdc.gov/ncidod/dvbid/westnile/wnv_DiagnosticTesting.html. Accessed 1 October 2012.
28. Kuberski T, Herrig J, Pappagianis D. False-positive IgM serology in coccidioidomycosis. J Clin Microbiol 2010; 48:2047-9.